Patrick Gallagher
Corporate Officer/Principal at SENSEI BIOTHERAPEUTICS, INC.
Net worth: 34 130 $ as of 2024-04-29
Profile
Patrick Gallagher is currently the Chief Business Officer at Sensei Biotherapeutics, Inc. He previously worked as the Senior Director of Business Development at Radius Health, Inc. from 2016 to 2018.
From 2020 to 2022, he served as the Managing Director at Binney Street Partners, LLC.
Patrick also held positions at Pfizer Inc. as the Head of Sales & Marketing, AMAG Pharmaceuticals, Inc. as the Head of Business Development, and Celexion LLC as the Manager of Business Development.
Additionally, he worked as a Principal at Aquilo Partners LP from 2018 to 2020.
Patrick obtained a graduate degree in Masters of Business Administration from Boston University and an undergraduate degree from Ohio Wesleyan University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-02-14 | 34,130 ( 0.14% ) | 34 130 $ | 2024-04-29 |
Patrick Gallagher active positions
Companies | Position | Start |
---|---|---|
SENSEI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 2022-05-31 |
Former positions of Patrick Gallagher
Companies | Position | End |
---|---|---|
Binney Street Partners, LLC | Corporate Officer/Principal | 2022-05-31 |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Corporate Officer/Principal | 2019-12-31 |
RADIUS HEALTH, INC. | Corporate Officer/Principal | 2017-12-31 |
PFIZER, INC. | Sales & Marketing | - |
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Patrick Gallagher
Boston University | Graduate Degree |
Ohio Wesleyan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Finance |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Celexion LLC
Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Binney Street Partners, LLC |
- Stock Market
- Insiders
- Patrick Gallagher